Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artículo científico |
| Lingua: | en |
| Pubblicazione: |
Medical sciences (Basel, Switzerland)
2025
|
| Soggetti: | |
| Accesso online: | https://pubmed.ncbi.nlm.nih.gov/40843759/ |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1868266162705399808 |
|---|---|
| author | Abdelhady, Mai E Elmosalamy, Khaled H Kattaia, Asmaa A A Samak, Mai A |
| author_facet | Abdelhady, Mai E Elmosalamy, Khaled H Kattaia, Asmaa A A Samak, Mai A Abdelhady, Mai E Elmosalamy, Khaled H Kattaia, Asmaa A A Samak, Mai A |
| collection | PubMed - marine biology |
| contents | Effect of Versus Simvastatin on the Skeletal Muscles of Experimentally Induced Dyslipidemia: A Multitarget Approach to Muscle Ultrastructural and Cytomolecular Modulation. Abdelhady, Mai E Elmosalamy, Khaled H Kattaia, Asmaa A A Samak, Mai A Animals Spirulina Simvastatin Male Dyslipidemias Muscle, Skeletal Rats Diet, High-Fat Muscular Diseases Malondialdehyde Creatine Kinase Dyslipidemia is a prevalent metabolic disorder closely linked to cardiovascular complications and muscular pathologies, often managed using statins such as simvastatin. However, statin-induced myopathy remains a significant treatment-limiting side effect, necessitating the exploration of safe, natural alternatives. , a phytochemical-rich marine-derived cyanobacterium, has emerged as a promising bioactive nutraceutical with potent antioxidant and anti-inflammatory properties. This study evaluated the comparative effects of and simvastatin in attenuating dyslipidemia-induced skeletal muscle injury in adult male albino rats. Forty animals were allocated to the control and high-fat diet (HFD) groups. After 4 weeks, the dyslipidemic rats were subdivided into untreated, simvastatin-treated, and -treated subgroups. Serum lipid profile, creatine kinase (CK), and malondialdehyde (MDA) levels were assessed. Histological, ultrastructural, and immunohistochemical analyses were conducted to assess muscle fiber integrity and expression of TGF-β1 and Bcl2. significantly improved lipid parameters, reduced CK and MDA levels, preserved muscle histoarchitecture, and downregulated fibrotic (↓TGF-β1) and apoptotic (↑Bcl2) responses compared to the dyslipidemic and simvastatin-treated groups. Our results proved that ameliorates the effects of statin-associated myopathy while exerting lipid-lowering, cytoprotective, and antifibrotic effects. These molecular and ultrastructural benefits position as a promising, natural alternative to statins for managing dyslipidemia and preventing statin-induced myopathy. Future translational and clinical studies are warranted to further validate its efficacy and safety, supporting its broader application in metabolic and muscle-related disorders. |
| format | Artículo científico |
| id | pubmed_40843759 |
| institution | PubMed |
| language | en |
| publishDate | 2025 |
| publisher | Medical sciences (Basel, Switzerland) |
| record_format | pubmed |
| spellingShingle | Effect of Versus Simvastatin on the Skeletal Muscles of Experimentally Induced Dyslipidemia: A Multitarget Approach to Muscle Ultrastructural and Cytomolecular Modulation. Abdelhady, Mai E Elmosalamy, Khaled H Kattaia, Asmaa A A Samak, Mai A Animals Spirulina Simvastatin Male Dyslipidemias Muscle, Skeletal Rats Diet, High-Fat Muscular Diseases Malondialdehyde Creatine Kinase Effect of Versus Simvastatin on the Skeletal Muscles of Experimentally Induced Dyslipidemia: A Multitarget Approach to Muscle Ultrastructural and Cytomolecular Modulation. Abdelhady, Mai E Elmosalamy, Khaled H Kattaia, Asmaa A A Samak, Mai A Animals Spirulina Simvastatin Male Dyslipidemias Muscle, Skeletal Rats Diet, High-Fat Muscular Diseases Malondialdehyde Creatine Kinase Dyslipidemia is a prevalent metabolic disorder closely linked to cardiovascular complications and muscular pathologies, often managed using statins such as simvastatin. However, statin-induced myopathy remains a significant treatment-limiting side effect, necessitating the exploration of safe, natural alternatives. , a phytochemical-rich marine-derived cyanobacterium, has emerged as a promising bioactive nutraceutical with potent antioxidant and anti-inflammatory properties. This study evaluated the comparative effects of and simvastatin in attenuating dyslipidemia-induced skeletal muscle injury in adult male albino rats. Forty animals were allocated to the control and high-fat diet (HFD) groups. After 4 weeks, the dyslipidemic rats were subdivided into untreated, simvastatin-treated, and -treated subgroups. Serum lipid profile, creatine kinase (CK), and malondialdehyde (MDA) levels were assessed. Histological, ultrastructural, and immunohistochemical analyses were conducted to assess muscle fiber integrity and expression of TGF-β1 and Bcl2. significantly improved lipid parameters, reduced CK and MDA levels, preserved muscle histoarchitecture, and downregulated fibrotic (↓TGF-β1) and apoptotic (↑Bcl2) responses compared to the dyslipidemic and simvastatin-treated groups. Our results proved that ameliorates the effects of statin-associated myopathy while exerting lipid-lowering, cytoprotective, and antifibrotic effects. These molecular and ultrastructural benefits position as a promising, natural alternative to statins for managing dyslipidemia and preventing statin-induced myopathy. Future translational and clinical studies are warranted to further validate its efficacy and safety, supporting its broader application in metabolic and muscle-related disorders. |
| title | Effect of Versus Simvastatin on the Skeletal Muscles of Experimentally Induced Dyslipidemia: A Multitarget Approach to Muscle Ultrastructural and Cytomolecular Modulation. |
| topic | Animals Spirulina Simvastatin Male Dyslipidemias Muscle, Skeletal Rats Diet, High-Fat Muscular Diseases Malondialdehyde Creatine Kinase |
| url | https://pubmed.ncbi.nlm.nih.gov/40843759/ |